215
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

Cost-Effectiveness of Biphasic Insulin Aspart 30 VS. Human Premix Insulin in Type 2 Diabetes from the Payer's Perspective in Bulgaria

, , , &
Pages 2937-2944 | Published online: 16 Apr 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Miglena Doneva, Vasil Valov, Anna-Maria Borisova, Tsvetalina Tankova, Alexandra Savova, Manoela Manova, Marcin Czech & Guenka Petrova. (2013) Comparative Analysis of the Cost of Insulin Treated Patients in Bulgaria. Biotechnology & Biotechnological Equipment 27:2, pages 3748-3752.
Read now

Articles from other publishers (3)

Xinyang Hua, Thomas Wai-Chun Lung, Andrew Palmer, Lei Si, William H. Herman & Philip Clarke. (2016) How Consistent is the Relationship between Improved Glucose Control and Modelled Health Outcomes for People with Type 2 Diabetes Mellitus? a Systematic Review. PharmacoEconomics 35:3, pages 319-329.
Crossref
Amir Farshchi, Rokhsareh Aghili, Maryam Oskuee, Marjan Rashed, Sina Noshad, Abbas Kebriaeezadeh, Maryam Kia & Alireza Esteghamati. (2016) Biphasic insulin Aspart 30 vs. NPH plus regular human insulin in type 2 diabetes patients; a cost-effectiveness study. BMC Endocrine Disorders 16:1.
Crossref
Olena Mandrik, Saskia Knies, Zoltan Kalo & Johan L. Severens. (2016) REVIEWING TRANSFERABILITY IN ECONOMIC EVALUATIONS ORIGINATING FROM EASTERN EUROPE. International Journal of Technology Assessment in Health Care 31:6, pages 434-441.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.